These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3141096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 5. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R, Louie TJ, Mandell L, Bow EJ, Robson HG, Chow A, Belch A, Miedzinski L, Rachlis A, Pater J.
    Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
    [Abstract] [Full Text] [Related]

  • 6. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
    Fainstein V, Bodey GP, Bolivar R, Elting L, McCredie KB, Keating MJ.
    Arch Intern Med; 1984 Sep; 144(9):1766-70. PubMed ID: 6383246
    [Abstract] [Full Text] [Related]

  • 7. Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.
    Bow EJ, Louie TJ.
    CMAJ; 1987 Sep 01; 137(5):397-403. PubMed ID: 3304600
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
    Scaglione C, López H, Fernández A, Marcenac F, Garay G, Dupont J, Pavlovsky S.
    Medicina (B Aires); 1981 Sep 01; 41 Suppl():29-34. PubMed ID: 6954341
    [No Abstract] [Full Text] [Related]

  • 10. A study of various antibiotic combinations for the empiric treatment of neutropenic febrile children.
    Anak S, Devecioğlu O, Ağaoğlu L, Zülfikar B, Ayan I, Atilgan N, Yalman N, Bilgen H, Kaya G, Gedikoğlu G.
    Bone Marrow Transplant; 1989 Dec 01; 4 Suppl 3():104. PubMed ID: 2697388
    [No Abstract] [Full Text] [Related]

  • 11. [Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors].
    Natali M, Tonini G, Tufo E, Leggio M, Carassai A, Lopez M.
    Clin Ter; 1989 Sep 15; 130(5):239-44. PubMed ID: 2530024
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
    Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E, Schmitt J, Adam D.
    Med Klin (Munich); 1994 Mar 15; 89(3):114-23. PubMed ID: 8196571
    [Abstract] [Full Text] [Related]

  • 15. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA, Joshi JH, Thompson BW, Newman KA, Finley RS, Moody MR, Salvatore PC, Tenney JH, Drusano GL, Schimpff SC.
    Am J Med; 1986 May 30; 80(5C):101-11. PubMed ID: 3521269
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A, Bucaneve G.
    Rev Clin Exp Hematol; 2005 Dec 30; 9(2):E4. PubMed ID: 16864118
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA, Butler T, Beveridge RA, Kales AN, Binder RA, Smith LJ, Ueno WM, Milkovich G, Goldwater S, Marion A.
    Clin Ther; 1993 Dec 30; 15(3):486-99. PubMed ID: 8364941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.